Kangbuk Samsung Hospital Develops Model to Identify Breast Cancer Patients Who Can Avoid Axillary Lymph Node Surgery
Five Indicators Predict Occult High-Risk Lymph Node Metastasis
A research team at Kangbuk Samsung Hospital has developed a predictive scoring model to identify breast cancer patients who may be able to avoid extensive removal of the axillary lymph nodes. The model uses five clinical and pathological indicators to predict occult high-risk lymph node metastasis. Among patients classified as low risk, 96.1% were found not to have high-risk lymph node metastasis.
Kangbuk Samsung Hospital said on November 4 that a research team led by Lee Gwanho, professor of surgery, had developed a scoring model to predict the likelihood of occult high-risk lymph node metastasis using clinical and pathological findings in patients with hormone receptor-positive, HER2-negative breast cancer.
Lee Kwanho, professor of surgery at Kangbuk Samsung Hospital. Kangbuk Samsung Hospital
View original imageIn breast cancer surgery, sentinel lymph node biopsy, which removes some of the axillary lymph nodes, is widely performed to determine whether the cancer has spread to the lymph nodes. By contrast, axillary lymph node dissection, which involves extensive removal of the axillary lymph nodes, is being performed less frequently to reduce the risk of postoperative complications such as lymphedema.
However, if dissection is omitted, a patient's cancer may be understaged based on only one to three metastases found in the sentinel lymph nodes, even when four or more lymph nodes are actually affected. This can also affect decisions about adjuvant treatment after surgery. In hormone receptor-positive, HER2-negative breast cancer, the extent of lymph node metastasis can determine whether a patient is eligible for abemaciclib, a targeted therapy that lowers the risk of recurrence. It can also affect decisions about chemotherapy based on genetic test results.
To investigate this issue, the research team analyzed 160 patients with hormone receptor-positive, HER2-negative breast cancer who underwent surgery at Kangbuk Samsung Hospital between 2015 and 2022 and had metastases in one to three sentinel lymph nodes.
The results showed that 17.5% of all patients actually had metastases in four or more lymph nodes. Four types of imaging performed before surgery—ultrasound, MRI, PET-CT, and CT—did not significantly predict occult high-risk lymph node metastasis.
The research team developed a risk scoring model that assigns one point to each of five clinical and pathological indicators: metastases in two or more sentinel lymph nodes; lymphovascular invasion; a tumor measuring 2 cm or larger; a Ki-67 index of 20% or higher; and multiple tumors.
The analysis found that the low-risk group, with scores of 0 to 1, accounted for about 32% of all patients (51 people). Among them, only 3.9% had metastases in four or more lymph nodes. The negative predictive value—the likelihood that patients in the low-risk group did not have occult high-risk lymph node metastasis—was 96.1%.
Notably, none of the 43 patients in the low-risk group who were not eligible for abemaciclib treatment under existing criteria had occult high-risk lymph node metastasis. Based on this finding, the research team suggested that omitting dissection in this patient group could reduce the risk of patients being excluded from targeted therapy because of undetected metastasis. The analysis also found that applying the risk score could reduce unnecessary axillary lymph node dissections by about 14 per 100 patients.
"None of the patients who underwent sentinel lymph node biopsy alone developed lymphedema. Avoiding dissection can make a major difference to patients' quality of life," said Lee Gwanho, professor of surgery at Kangbuk Samsung Hospital. "This study presents an approach that considers both the possibility of omitting axillary lymph node dissection to reduce postoperative complications such as lymphedema and the need to ensure appropriate opportunities for adjuvant treatment through accurate staging."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
"We expect this approach to help assess each patient's risk more accurately, reduce the burden of unnecessary surgery, and ensure that patients do not miss out on necessary treatment," he added. "However, because this was a retrospective study conducted at a single institution, external validation involving more patients at multiple institutions is needed before the findings can be applied in clinical practice." The results were published in the latest issue of Annals of Surgical Oncology, the official journal of the American Society of Surgical Oncology.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.